Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor

Background. Ivacaftor improves outcomes in cystic fibrosis (CF) patients with the G551D mutation; however, effects on respiratory microbiology are largely unknown. This study examines changes in CF respiratory pathogens with ivacaftor and correlates them with baseline characteristics and clinical re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Autores principales: Heltshe, Sonya L., Mayer-Hamblett, Nicole, Burns, Jane L., Khan, Umer, Baines, Arthur, Ramsey, Bonnie W., Rowe, Steven M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2015
Materias:
Articles and Commentaries
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342673/
https://ncbi.nlm.nih.gov/pubmed/25425629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu944
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares